Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 05

1863P - Compassion fatigue among the staff involved in medical carcinology services

Date

21 Oct 2023

Session

Poster session 05

Topics

Psycho-Oncology

Tumour Site

Presenters

Nouha Abidi

Citation

Annals of Oncology (2023) 34 (suppl_2): S1001-S1012. 10.1016/S0923-7534(23)01947-6

Authors

N.A. Abidi

Author affiliations

  • Medecine, University of Sfax - Faculty of Medicine, 3029 - Sfax/TN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1863P

Background

A descriptive, cross-sectional, multicenter study was carried out among the nursing staff working in several departments caring for cancer patients (Carcinology Sousse, Monastir, Sfax, Institut Salah Azaiez and Ariana).

Methods

The instrument used to measure CE was the "Professional quality of life" (PRO-QOL version5), which is composed of 3 subscales: 10 items to measure compassion satisfaction (SC), 10 items to measure professional exhaustion (PE) and 10 items to measure secondary traumatic stress (STS).

Results

A total of 120 health personnel responded to the questionnaire. The average age of the participants was 36.13±8.06 with a clear female predominance (sex ratio=0.29). Most respondents were physicians (55.9%). The mean CS score was 33.57±6.24, which is consistent with an average level of CS. However, 13.3% of the staff had a high SC score. The mean PE score was 29.88±5.12, which corresponds to an average level of PE. Only 10.9% had a low PE score. The mean STS score was 33.16±7.56, which corresponds to an average level of STS. However, 17.5% had a high STS score.

Conclusions

Compassion fatigue can lead to real burnout. Its prevention, detection and implementation of solutions to stem the process is essential.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

1-Service of carcinological medicine CHU FarhatHached Sousse 2- Hospital hygiene service CHU FarhatHached Sousse 1-Service of carcinological medicine CHU FarhatHached Sousse 2- Hospital hygiene service CHU FarhatHached Sousse Service of carcinological medicine CHU FarhatHached Sousse and Hospital hygiene service CHU FarhatHached Sousse.

Funding

Has not received any funding.

Disclosure

The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.